Fierce Life SciencesUnclaimed
Host of The Top Line.
Host, The Top Line
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
About
Fierce hosts The Top Line.
Written by PodSubs from Fierce's credits.
PodCred record
PodCred is the verified record of where Fierce has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with Fierce on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when Fierce claims this profile.
Recommendations
No recommendations for Fierce yet.
Recommendations open once Fierce claims the profile.
Recent episodes
From the shows they work on now
Mapping psychedelics’ commercial summit
Several years after the FDA's high-profile rejection of Lykos Therapeutics’ MDMA candidate for post-traumatic stress disorder, a new wave of developers is nearing the regulatory finish line with experimental psychedelic...
Reducing Protocol Burden to Improve Trial Performance (Sponsored)
Clinical trial teams face a difficult balance: preserve scientific rigor while making protocols feasible for sites and participants. In this sponsored episode of The Top Line, host Kelly Hogan speaks with Metta...
Digital Twins: Advancing Clinical Evidence Strategy (Sponsored)
Patient digital twins give life sciences teams a framework for evaluating how an individual patient’s health trajectory could change under different treatments or scenarios. In this sponsored episode of The Top Line,...
The promise of molecular gates and what comes next
Gate Bioscience is betting that a decades-old biological mechanism could pave the way for a new class of medicines. The biotech is developing small molecules that selectively block disease-causing proteins from passing...
How Smarter Healthcare Environments Improve Patient Experience (Sponsored)
Patient experience is shaped by more than clinical care. It begins with transportation, parking and wayfinding, and continues through check-in, the patient room, diagnostics and follow-up. In this sponsored episode of...
Use Kidney Genetics to Strengthen Clinical Trial Design (Sponsored)
Broad chronic kidney disease labels can obscure distinct biology, complicating patient selection, progression assumptions and treatment-signal interpretation. In this sponsored episode of The Top Line, Will Hurth speaks...
When China Fits a Global Clinical Development Strategy (Sponsored)
China can play several roles in a global clinical development program, from supporting a capital-efficient proof-of-concept study to contributing evidence within a multiregional clinical trial. In this sponsored episode...
There's more than one way to build a biotech
As biotech companies continue to navigate a challenging funding environment, Axiom Biosciences is taking an unconventional approach to raising capital and developing new therapies. The company is pursuing a public...
When drug development gets personal
For nearly three decades, Jigar Raythatha has helped build biotech companies and bring new medicines to patients. But in 2023, the Third Rock Ventures partner found himself on the other side of drug development when he...
How AI turns field conversations into actionable insights (Sponsored)
Life science field teams are a major source of customer insight, but growing complexity, limited HCP access and expanding omnichannel demands can make it difficult to turn every interaction into action. In this...
